Clinical Trials Browser

Phase 3 × Neoplasm Metastasis × sacituzumab govitecan × Clear all

NCT05552001 2025-06-11

ISIdE

Phase 3 Recruiting

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms